In vitro susceptibility of oral Candida to seven antifungal agents
- 14 October 2005
- journal article
- research article
- Published by Wiley in Oral Microbiology and Immunology
- Vol. 20 (6), 349-353
- https://doi.org/10.1111/j.1399-302x.2005.00236.x
Abstract
The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, ketoconazole, miconazole, amphotericin B, and nystatin was determined. The isolates were obtained from 559 patients who had attended the UK dental hospital departments in Cardiff, Belfast, Glasgow or London. Antifungal susceptibility was assessed using a broth microdilution method following the National Committee for Clinical Laboratory Standards (NCCLS) M27-A guidelines. The majority of the test strains were C. albicans (n = 521) with few of these being resistant to fluconazole (0.3%). A low incidence of fluconazole resistance (0-6.8%) was similarly evident with all non albicans species (Candida glabrata, 5 of 59 resistant; Candida krusei, 0 of 7 resistant; Candida tropicalis, 0 of 13 resistant; Candida parapsilosis, 0 of 12 resistant; other Candida species, 0 of 6 resistant). Voriconazole, ketoconazole, and miconazole also revealed high activity against both C. albicans and non albicans isolates, and 23.7% of C. glabrata isolates were found to be resistant to itraconazole. There was little difference in the antifungal susceptibilities of Candida isolated from patients who had a history of previous antifungal therapy compared with those who had not received antifungal treatment. In summary, this surveillance study of antifungal susceptibility of oral candidal isolates in the UK, through the collaboration of four dental hospitals, demonstrates that oral Candida species have a high level of susceptibilities to a range of antifungal agents.Keywords
This publication has 20 references indexed in Scilit:
- Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001Journal of Clinical Microbiology, 2003
- Frequency and clinical significance of bloodstream infections caused by C. albicans strains with reduced susceptibility to fluconazoleDiagnostic Microbiology and Infectious Disease, 2002
- Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida IsolatesAntimicrobial Agents and Chemotherapy, 2002
- Fluconazole and Voriconazole Multidisk Testing of Candida Species for Disk Test Calibration and MIC EstimationJournal of Clinical Microbiology, 2001
- Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?Antimicrobial Agents and Chemotherapy, 2000
- Cross-resistance phenotypes of fluconazole-resistant Candida species: Results with 655 clinical isolates with different methodsDiagnostic Microbiology and Infectious Disease, 1996
- Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patientsreceiving long-term continuous versus intermitent fluconazole therapyAIDS, 1996
- Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype AnalysisClinical Infectious Diseases, 1994
- Yeast species and biotypes associated with oral leukoplakia and lichen planusOral Surgery, Oral Medicine, Oral Pathology, 1987
- A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavityJournal of Oral Pathology & Medicine, 1986